7 Stellar Stocks Below 5¢ Spark Investor Interest: $CLNV, $HNRC, $RSHN, $SPZI, $HALB, $ENZC, $SINT


https://thestreetreports.com/magnificent-7-stocks-under-5%c2%a2-clnv-hnrc-rshn-spzi-halb-enzc-tptw/

There are numerous stocks that consistently attract investor attention due to their core businesses and significance in the market. This article examines some of these stocks currently trading below 5 cents per share. Here are seven such stocks that investors may find worth monitoring.

Clean Vision Corporation (OTC: CLNV), a rising player in clean fuel innovation and plastic recycling, disclosed on February 20 that it secured a $15 million loan guarantee sanctioned by the West Virginia Economic Development Authority. This funding is slated to accelerate the progress of its inaugural PCN (plastic conversion network) facility in the United States, situated in Quincy under the Clean Seas West Virginia division.

Houston Natural Resources Corporation (OTC: HNRC), an oil and natural gas enterprise, revealed its financial outcomes on March 19, 2024, for the fiscal period concluding on December 31, 2023. The company reported revenues of $21,117,265, marking a 2.9% increase from the previous fiscal year. Moreover, total earnings surged by 19.3% to $11,501,687 compared to $9,641,297 in the 2022 fiscal year. As of year-end, the company’s net asset value stood at $0.42 per share.

RushNet Inc. (OTC: RSHN) recent announcement regarding Fuel Tech Inc.’s publication of a white paper detailing the successful trial of Fuel Tech’s DGI Dissolved Gas Infusion Technology at Royal Caridea’s Gila Bend, Arizona, facility. The white paper highlighted that this technology has the potential to significantly increase shrimp size while reducing production time compared to traditional methods.

Spooz Inc. (OTC: SPZI), now operating as JP 3E Holdings Inc., revealed on March 21 that it had engaged Ancell Audit & Compliance PA to audit its financial statements. The purpose of this audit, as highlighted by Spooz Inc., was to achieve full SEC reporting status, marking the initial step towards potential up-listing on the OTCQB. Ancell Audit & Compliance PA serves a diverse clientele spanning various industries, offering its services to numerous companies.

Halberd Corporation (OTC: HALB) shared on April 4th that its patented LDN+ drug had reached a significant milestone by entering the safety trial protocol within the framework of a CRADA contract designed for military personnel, both active duty and veterans. The company mentioned that the six-week safety study for the drug would encompass participation from both retired and currently active-duty volunteers.

Enzolytics Inc. (OTC: ENZC) gained attention on April 12th following its announcement about a new business direction. Steve Sharabura, the interim CEO of Enzolytics Inc., highlighted that he and the board of directors had identified specific acquisition targets and markets for implementing the company’s new strategy.

SINTX Technologies Inc. (NASDAQ: SINT) emerged as one of the top performers in today’s trading, soaring by 82% to $0.042. Earlier this month, the company priced 71,600,000 shares of its common stock at $0.021 per share, anticipating gross proceeds of about $1.5 million, excluding placement agent fees and estimated offering expenses.

Exploring Stock Surges: Key Insights, Noteworthy Buzz: $KAVL, $PRSO, $DYAI, $WISA, $JAGX

https://thestreetreports.com/exploring-stock-surges-key-insights-noteworthy-buzz-kavl-prso-dyai-wisa-jagx/

Several companies have attracted investor attention recently due to movements in their stock prices. This article offers an in-depth analysis of five such companies.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) experienced an impressive 135% surge in its stock value on Monday amid active trading. The company is known for being the exclusive distributor of Bidi Vapor LLC products, particularly the BIDI® Stick, tailored for legal-aged nicotine users in the U.S. On March 25, Kaival Brands disclosed its financial results for the first quarter of fiscal 2024, ending on January 31, 2024. The company reported strong revenues of $3.2 million for the quarter, a notable increase from the previous year’s $2.5 million. In 2022, a significant agreement was forged with Phillip Morris Products SA (NYSE: PM) for the distribution, advancement, and development of VEEBA®, a disposable vape product, similar to BIDI® Stick. VEEBA® aims to provide convenience and simplicity for legal-aged nicotine users, offering a wide range of globally available flavors. Both companies are aligned in their mission to combat cigarette smoking.

Peraso Inc. (NASDAQ: PRSO) garnered attention on April 16 when it revealed that Panasonic System Networks R&D Lab Co. Ltd. (PSNRD) had chosen its X710 chipset for a new 60GHz WLAN solution. By integrating Peraso Inc.’s phased array antenna technology, PSNRD’s product promises low-latency communication and high-speed performance comparable to wired LAN, spanning hundreds of meters. This selection by a unit of Panasonic, a renowned global technology leader in consumer and enterprise sectors, marked a significant milestone for Peraso. The 60 GHz frequency band offers an expansive RF spectrum with advanced capabilities.

Dyadic International Inc. (NASDAQ: DYAI) In March 2024, the company released its financial results for the fiscal year 2023, with the company reporting revenues of $2,899,000 and cash, cash equivalents, and investment-level securities valued at $7.3 million at the end of the fiscal year. Additionally, the company successfully concluded a $6 million capital raise, sourced from relatives, trusts, and long-standing DYAI shareholders linked to Mark Emalfarm, the company’s CEO. This infusion has bolstered the company’s robust capital position. See Zacks Small-Cap Research Report, updated April 1, 2024. Finally, CEO Mark Emalfarb highlighted Dyadic’s accomplishments on “The Street Podcast,” highlighting the $75 million DuPont (NYSE: DD) deal and drawing parallels between Dyadic and Tesla, Inc.’s (NYSE: TSLA) transformative impact on the auto industry. Listen Now!

WiSA Technologies Inc. (NASDAQ: WISA) made headlines on April 16 with news that its subsidiary, WiSA Association, had finalized its fourth 5-year WiSA E licensing agreement with a prominent PTV/HDTV brand. According to the company’s press release, the WiSA E license allows the brand to integrate WiSA E software into its products, offering customers a range of wireless audio features. These features include compatibility with any WiSA-powered speakers from brands associated with the WiSA association. This development marked a significant milestone as the fourth HDTV brand to recognize the technology’s value and the licensing model provided by WiSA Technologies for market deployment.

On April 16, Jaguar Health Inc. (NASDAQ: JAGX) made headlines with the announcement of a 5-year licensing agreement with Venture Life Group PLC, an international consumer health company based in the UK. The agreement focuses on the oral mucusitis prescription product Gelclair, intended for the U.S. market and already approved by the FDA. While the treatment’s cost could reach up to $17,000 for patients, Gelclair offers a user-friendly, fast-acting, and durable pain relief solution.

$KAVL Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Stock Hits 6-Month High: What’s Ahead?


https://thestreetreports.com/kaival-brands-innovations-group-inc-nasdaq-kavl-stock-hits-6-month-high-whats-ahead/

On April 15, 2024, Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) saw substantial gains, with its stock soaring by up to 135% by the day’s close. The company, known for distributing the BIDI® Stick, a disposable product containing 6% class A nicotine for a satisfying nicotine experience, utilizes advanced manufacturing and product engineering techniques. Available in various flavors nationwide, Kaival Brands may have attracted significant attention from investors due to its impressive stock performance.

Yesterday, the stock reached a new intra-day high, marking its highest point since October 2023. Currently, it is trading significantly above its 20-day and 50-day moving averages, which stand at $3.19 and $2.55, respectively. This robust performance may offer strong support for the stock in the future.

In the first quarter 2024, Kaival Brands saw revenues of $3.2 million, marking an improvement from the $2.5 million in the same quarter of the previous year. This increase in revenue was primarily due to fewer credits issued to customers. The net loss for the quarter was $2.2 million, or $0.76 per basic and diluted share, compared to a net loss of $3 million, or $1.12 per basic and diluted share, in the previous year’s quarter. The decrease in net losses was driven by higher revenues and reduced operating expenses, which totalled $2.9 million for the quarter compared to $3.5 million in the prior-year period.

In 2022, Kaival Brands made a significant move by partnering with Philip Morris International LLC affiliate Phillip Morris Products SA (NYSE: PM) to distribute and develop VEEBA®, a disposable vape product. Similar to the successful BIDI® Stick, VEEBA® aims to offer convenience and simplicity for legal-aged nicotine users, with a wide range of flavors available globally. BIDI® Stick has gained traction in Canada and numerous European countries. This agreement focused on distributing products internationally, expanding Kaival Brands’ reach beyond the United States.

The agreement was facilitated by Kaival Brands Innovations LLC, a wholly-owned subsidiary of the company. Partnering with the tobacco giant Phillip Morris (NYSE: PM) and its affiliate marked a significant expansion for Kaival Brands, propelling its presence to new heights. Both companies shared a common goal: to combat cigarette smoking.

Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB


https://thestreetreports.com/stocks-in-the-news-in-april-2024-inbs-gevi-vtak-kavl-rlyb/

As the trading week approaches, now is an opportune moment for investors to delve deeper into companies garnering recent attention. This feature will offer insights into five such stocks.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) has shown robust performance recently, accompanied by a significant increase in trading volume. Since March 20, the stock has surged by 121% and closed at $2.95 per share on April 11, driven by a prolonged short squeeze. On March 27, the company released its financial results for the fiscal year ending January 31, 2024. Quarterly revenues rose to $3.2 million from $2.5 million in the corresponding period last year, mainly due to reduced credits issued to customers. The net loss for the quarter was $2.2 million, marking a decrease from the previous year’s net loss of $3 million.

Intelligent Bio Solutions Inc. (NASDAQ: INBS), a key player in the medical technology sector, specializes in providing fast, non-invasive, and intelligent testing solutions. Ladenburg Thalmann, a well-known Wall Street institution established in 1876, issued a buy recommendation for Intelligent Bio Solutions Inc. stock, setting a target price of $12 per share. Furthermore, on March 11, the company announced raising $10.1 million through a private placement involving accredited investors in the healthcare sector and institutional investors. On April 11, the company expanded the intellectual property portfolio of its wholly owned subsidiary, Intelligent Fingerprinting Limited, by securing a new European patent with unitary effect for its innovative DSR-Plus Cartridge Reader.

General Enterprise Ventures Inc. (OTC: GEVI) gained recognition primarily for the advancements made by its subsidiary, Mighty Fire Breaker LLC (MFB), in the field of fire-retardant solutions. In April, it was revealed that Joshua Robinson, the Chief Executive Officer of General Enterprise Ventures Inc., had returned 60% of the company’s outstanding common stock shares to the Treasury, a move expected to significantly enhance shareholder value. On April 2, news surfaced about a collaboration between SkyScout Ai Innovations and MFB’s Value-Add Wildfire Reduction Team, signaling MFB’s entry into the Canadian market with its fire-retardant product CitroTech.

Catheter Precision Inc. (NYSE American: VTAK) was highlighted in a Ladenburg Thalmann research report on April 5, 2023, with a buy recommendation and a $4 target price for the next year. On April 1, the company reported its Q4 and full fiscal year results for 2023, showing total assets of $30.7 million, a cash balance of $3.6 million, and notable revenue growth compared to the previous year. The company also reduced its net loss in the fourth quarter to $0.7 million from $8.2 million. Additionally, on April 4, Catheter Precision expanded its business development team with industry professionals to drive sales growth and market expansion.

Rallybio Corporation (NASDAQ: RLYB) gained attention on April 10 following its announcement of a collaboration with Johnson & Johnson. Under the agreement, Rallybio Corporation will assist in developing complementary therapeutic methods to reduce the risk of FNAIT (fetal and neonatal alloimmune thrombocytopenia). Additionally, Johnson & Johnson Innovations invested $6.6 million in Rallybio Corporation as part of the collaboration.

$ASRE Form 10k - Filed 04/09/24 for the Period Ending 02/29/24

https://www.otcmarkets.com/filing/conv_pdf?id=17439026&guid=yzQ-kHlLxd1joVh

Exploring 5 Promising Stocks: GEVI, HALB, HNRC, CLNV, SIGL

https://thestreetreports.com/exploring-5-promising-stocks-gevi-halb-hnrc-clnv-sigl/

Successful investors typically conduct thorough research and closely monitor market developments. Recently, several stocks have demonstrated significant gains, and this article offers an in-depth analysis of five such stocks.

General Enterprise Ventures Inc. (OTC: GEVI): subsidiary Mighty Fire Breaker LLC (MFB), “Tapping into Safe Fire-Retardant Chemistry” has experienced a gradual increase in trading volume recently, accompanied by a consistent upward trend. On April 2, news emerged of the MFB Value Add Wildfire Risk Reduction Team’s ongoing discussions with SkyScout AI Innovations in Vancouver, Canada, spanning several months. The collaboration aims to introduce MFB’s CitroTech product to Canada, addressing the critical need for safe fire-retardant chemistry in the region.

Halberd Corporation (OTC: HALB) “Advancing with LDN+ Drug in Military Safety Trial”, made headlines on April 4 with the announcement of a significant achievement regarding its patented LDN+ drug. The company revealed that the product had reached a crucial milestone by entering a major safety trial protocol outlined in a CRADA (Cooperative Research and Development Agreement) contract for military personnel, including active-duty members and veterans. The safety study, scheduled to last six weeks, will involve both current and retired military personnel as subjects and will commence after receiving approval from the Institutional Review Board (IRB).

Houston Natural Resources Corporation (OTC: HNRC) an undervalued oil and gas stock worth monitoring “Uncovering Value in Oil and Gas”. On March 19, 2023, Houston Natural Resources Corporation disclosed its financial outcomes for the fiscal year ending December 31, 2023. The company reported revenues of $21,117,265, marking a 2.9% increase compared to the previous year. Total earnings for the period amounted to $11,501,687, reflecting a 19.3% rise from the previous fiscal year, with earnings per share reaching $0.06.

Clean Vision Corporation (OTC: CLNV) “Accelerating Clean Fuel Development and Innovative Plastic Recycling” has witnessed a notable rise in trading volume recently, indicating a promising opportunity for investors to watch. The company, renowned for its innovations in clean fuel development and plastic recycling, announced on February 15 the approval of a $15 million loan guarantee by the West Virginia Economic Development Authority. This guarantee will expedite the establishment of Clean Vision Corporation’s first PCN (plastic conversion network) in Quincy, a significant milestone in its U.S. operations.

Signal Advance Inc. (OTC: SIGL) “Innovating Data Protection Solutions” have had a positive week, with the stock gaining 26.61%. Recently, the company introduced Analog Guard, a product designed to address consumer data protection requirements. Signal Advance Inc. highlighted Analog Guard’s unique features, allowing users to monitor the security of data storage, financial transactions, industrial controls, defense systems, and communications. Notably, Signal Advance’s stock experienced a surge in the past following misinterpreted Elon Musk’s tweet “use Signal” endorsing the Signal messaging app.

Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements

https://thestreetreports.com/momentum-stocks-alert-dyai-kavl-vtak-nkla-atai-demonstrate-financial-growth-and-strategic-advancements/

As the trading week nears its conclusion, investors may find it opportune to assess the market landscape and delve into companies that garnered attention during this period. This piece offers insights into five stocks that merit consideration for tracking purposes.

Dyadic International Inc. (NASDAQ: DYAI) has garnered significant attention from investors over the past month, with its stock showing a 31.91% increase in value within a 30-day period through yesterday. On March 29, Dyadic International Inc. released its financial results for the fiscal year 2023. The company reported revenues of $2,899,000 for the year ended December 31, 2023, a slight decrease the previous fiscal year. However, its net loss for the year decreased to $6.8 million, or $0.24 per share, down from $9.7 million, or $0.34 per share, in the previous year. The company’s cash, cash equivalents, and investment-level securities were valued at $7.3 million at the end of the fiscal year. Also, on March 11, 2024, the company successfully concluded a $6 million capital raise, sourced from relatives, trusts, and long-standing DYAI shareholders linked to Mark Emalfarm, the company’s CEO. This infusion has bolstered the company’s robust capital position. See Zacks Small-Cap Research Report, updated April 1, 2024.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Although the pullback in the price action in the company’s stock yesterday was interesting, it should be noted that up until April 3, it had clocked gains of 98.82% in 30 days. On March 25, Kaival Brands Innovations Group Inc. announced its financial results for the first fiscal quarter ended on January 31, 2024. The revenues for the quarter went up to $3.2 million from $2.5 million in the year-ago period, and the rise was attributed to the reduction of credits issued to customers. The net loss in the quarter was $2.2 million, which reflected a drop from the net loss of $3 million in the prior year.

Catheter Precision, Inc. (NYSE-American: VTAK), a prominent player in the medical technology sector, has experienced a surge in its stock value recently, making it an intriguing option for investors to monitor closely. On April 4, Catheter Precision Inc., renowned for its cardiac electrophysiology offerings, announced a significant expansion of its business development team. The company disclosed its strategic move to bolster its sales force by recruiting seasoned industry professionals, aiming to enhance market penetration and drive further growth. Notably, this new team has successfully propelled the sales figures of an electrophysiology products firm beyond the $100 million mark.

Nikola (NASDAQ: NKLA) experienced a robust surge in its stock value on Thursday, fueled by a significant development. The uptick followed Nikola’s impressive deliveries for the first quarter of 2024, surpassing analysts’ expectations. The company delivered 40 vehicles during the quarter, exceeding the consensus estimate of 30 deliveries by four analysts. Nikola’s production during this period totaled 43 units, contributing to its positive performance.

Atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical firm focused on revolutionizing mental health disorder treatments, disclosed its financial performance for the fourth fiscal quarter and the full fiscal year ending December 31, 2023, on March 28. The company reported net losses of $18.3 million and $40.2 million for the respective periods, showcasing a significant improvement compared to the net losses of $45 million and $152.4 million in the prior-year quarter and fiscal year.

$ASRE Form - 8k - entered into a Joint Venture Agreement (the "Agreement") with Powertron Global LLC

https://www.otcmarkets.com/filing/html?id=17420920&guid=J1Q-karWJBwfJth

Trump Media (NASDAQ: DJT) Soars 24%: Opens at $71.93, Ignites Market Buzz Among DYAI, INBS, VTAK

https://www.marketscreener.com/quote/stock/DIGITAL-WORLD-ACQUISITION-127708949/news/Trump-Media-NASDAQ-DJT-Soars-24-Opens-at-71-93-Ignites-Market-Buzz-Among-DYAI-INBS-VTAK-46310205/

The former United States President Donald J. Trump is making headlines due to the upcoming presidential elections as a candidate. However, he created buzz in the financial world after Trump Media & Technology Group Corp. (NASDAQ: DJT) went public yesterday. This company is the parent of Truth Social, his personal social media platform.

Trump Media & Technology Group Corp. (NASDAQ: DJT) commenced trading on Tuesday March 26, 2024. On its debut day of trading, the stock soared, achieving gains of up to 16%. The company went public through a merger with Digital World Acquisition Corp., (NASDAQ: DWAC) a special-purpose acquisition company (SPAC). The stock experienced significant pre-market trading activity today, with a substantial gap up of $71.93, marking a 24% increase from yesterday's closing price.

Shareholders approved the deal last week. Digital World Acquisition has been publicly listed since 2021. Trump Media & Technology Group's stock closed at $57.99 per share yesterday, giving it a market capitalization of approximately $8 billion. Donald Trump launched Truth Social after being banned from platforms like Twitter and Facebook post-Capitol riots on January 6, 2021. While he's back on those platforms, he remains active on Truth Social.

The former United States President Donald J. Trump owns approximately 60% of Truth Social, valued at $5 billion. Media incurred losses of $49 million in the first nine months, with revenues at $3.4 million during the same period. In any event this is an intriguing stock to monitor as it is expected to continue rising in the near term without showing signs of leveling off.

Dyadic International Inc. (NASDAQ: DYAI): CEO Mark Emalfarb highlights C1 Platform's Game-Changing Impact, Drawing Parallels to Tesla, Inc. (NYSE: TSLA)'s Automotive Industry Transformation on The Street Reports Podcast. Explore the Insights! Also, on March 26, 2024, Dyadic's Groundbreaking Manuscript, 'Filamentous Fungus-Produced Human Monoclonal Antibody Offers SARS-CoV-2 Protection in Hamster and Nonhuman Primate Models,' Published in Nature Communications, a Prestigious Global Journal Renowned for Cutting-Edge Science and Technology Journal. Dive into the Journal Review Now!

Intelligent Bio Solutions Inc. (Nasdaq: INBS) a medical technology company delivering intelligent, rapid, non-invasive testing solutions, announced they are scheduled to present at the LD Micro Invitational XIV Investor Conference to be held on April 8-9, 2024, in New York City. On March 12, 2024, Intelligent Bio Solutions Inc. announced that it had closed the private placement to generate gross proceeds to the tune of $10.1 million from the placement before the deduction of placement fees and other costs.

Catheter Precision Inc. (NYSE American: VTAK): Leading U.S. Medical Device Firm Specializing in Electrophysiology Products Featured in "MedTech Outlook". On March 14, 2024, Catheter Precision Inc. Debuts VIVO System in Pioneering Procedures at Hamad Medical Corporation Heart Hospital, Qatar's Premier Healthcare Institution. Explore VTAK's Innovations!

$LVVV Cannabis Industry in Trouble or Levelling Out? We are on the Offensive – Part 2

https://stockwatchindex.com/cannabis-industry-in-trouble-or-levelling-out-we-are-on-the-offensive-part-2/

No one said it would be easy. Well, quite a few people, cannabis experts, investors, and everybody who thought, “If you grow it, the money will flow,” did. Indeed, it did for a while, at least on paper, but then it did not anymore. Here is where the trouble started, and so many minor or large companies were unprepared. We have been preparing for this for several years. We are certainly ready.

Bill Hodson, Livewire’s CEO, states, “If you have been following our past releases, we did not fall into this trap. Keeping you updated via our press releases and Social Media partner networks reveals LiveWire’s dedication to guiding our shareholders and potential investors through California’s often confusing legal cannabis market. We moved ahead very cautiously in expanding our operation, realizing that we were involved in the complicated process of converting a wildly unconventional business into a transparent operation that satisfies all existing (and still changing) conditions. We continue on our path to prioritizing craft-style, sun-grown California cannabis with low overhead and building a consumer brand specific to the California market. Despite the well-known obstacles affecting the entire industry hindering rapid progress, companies that withstand the blows, navigate, and counterpunch effectively will seize the opportunities lying ahead.”

IN TROUBLED TIMES LIES OPPORTUNITY


Mr. Hodson continues:” We were always focused on building an operation that could sustain itself throughout troubled times and, at the same time, create value not only for our customers but also for our shareholders. We understand that it often seemed like a slow process and did not generate the share price expected by the market. Still, we have taken the intense experience of the last three years and have now, as we believe, reached a point enabling us to reap the benefits from this approach.

Monkey Rock Group Inc. (OTC: $MKRO ) Stock on Radar This Month

https://thestreetreports.com/monkey-rock-group-inc-otc-mkro-stock-on-radar-this-month/

Investors often seek hidden opportunities, requiring extensive research to discover them. This underexplored/undervalued company is Monkey Rock Group Inc. (OTC: MKRO), a company based in Italy within the European Union. It operates in the overnight shipping sector, competing with industry giants like FedEx Corporation (NYSE: FDX), United Parcel Service (NYSE: UPS), and (DHL Group) Deutsche Post (OTC: DHLGY).

Monkey Rock Group is active in warehouse handling, temporary work management, freight forwarding, and overland transportation. Since September of last year, it has served as an international operating subsidiary of GE Holding SRL.

GE Holding acquired controlling shares in Monkey Rock on August 8, 2023. Subsequently, GE Holding implemented a new board of directors, a seasoned management team, and engaged a PCOAB accounting firm to equip the company for a competitive edge in the global transportation sector.

After the transaction, Monkey Rock’s workforce expanded to over 1900 employees, overseeing 70 plants. Notably, the company achieved annual consolidated revenues amounting to $285 million.

Recently, it came to light that the company is in the process of finalizing its annual report, set to be completed before the March 31, 2024, filing deadline. Monkey Rock’s strategic objectives for the 2024 are not only focused on continuous improvements but also on strategic acquisitions aimed at fostering growth. Furthermore, the new management intends to decrease the number of issued common stock shares from the previous administration.

$VTAK Catheter Precision Inc. (NYSE American: VTAK) Surges with VIVO™ Success
https://thestreetreports.com/catheter-precision-inc-nyse-american-vtak-surges-with-vivo-success/

$WNLV “Winnie – The – Pooh” Prequel Feature in The Works By Winvest Subsidiary's IQI Media with Baboon Animation

https://www.otcmarkets.com/stock/WNLV/news/Winnie--The--Pooh-Prequel-Feature-in-The-Works-By-Winvest-Subsidiarys-IQI-Media-with-Baboon-Animation?id=433441

Reno, NV March 11, 2024 That cuddly bear and his motley pals are headed for the big screen, thanks to Baboon Animation and IQI Media, Inc., in a prequel to the A.A Milnes classic book Winne-the-Pooh.



Were tell the surprising origin story of the silly young bear and his friends, when they were still kids, in a way designed to connect with 21st-century kids, say Reynolds.



DreamWorks alumnus Mike de Seve (Madagascar, Monsters vs. Aliens) will direct, and co-write with fellow DreamWorks alum John Reynolds (The Mr. Peabody & Sherman Show).



Multi-Emmy-winning animation writing stars Baboon (Angry Birds, Gigantosaurus) have teamed up with IQI, a content incubator lab and subsidiary of WINVEST GROUP (OTCMKT:WNLV), to produce the prequel feature. DreamWorks alum Charlene Kelly (Next Gen), now CIO at Winvest, and Khiow Hui Lim, the founder of IQI and CSO of Winvest, will executive-produce.



A.A. Milnes bear has aged gracefully in the last hundred years, said Kelly. But what happened, back-when, that made him and his pals who they are in the book? A heck of a big adventure, thats what one that needs a big screen. Audiences will be transported to somewhere they never expected.



I think this unsinkable young cub is totally relatable for todays kids, with his hell-bent craving for honey and his ludicrous schemes to get it, adds de Seve, who directed on the original Beavis and Butt-Head series and feature and story-consulted on Shrek 2. He now helms Baboon, :The whole gang is hilarious, and are even more hilarious as kids, were finding out.



Noting the success of the reboots of Peter Rabbit and Paddington, the Baboon team is applying its knowledge of entertainment for todays kids to create characters they hope will resonate with all generations.



Baboon and IQI have set a planned release date of 2025 for the new feature, followed immediately by the series. What will the young bear and his friends look like? Youll see, laughed Kelly. Brace yourself for a surprise. Check out the Beyond Pooh Corner images and details at: https://iqimedia.com/beyond-pooh-corner



With 31 Emmys Collectively, Baboon Animations team members provide world-class show running, writing, development and voices on some of the most successful brands globally. For more details of Baboon Animation, please visit https://www.baboonanimation.com/



Charlene Kelly, Executive Producer at IQI Media and CIO at Winvest, and Khiow Hui Lim, the founder of IQI and CSO of Winvest, will executive-produce the project. Interested financial partners can visit their information at the website https://iqimedia.com/

$HNRC HNR Acquisition Corp. (NYSE: HNRA) Surges on Untapped Oil Discovery in Permian Basin; Houston Natural Resources Corp. (OTC: HNRC) Stocks Rally
https://thestreetreports.com/hnr-acquisition-corp-nyse-hnra-surges-on-untapped-oil-discovery-in-permian-basin-houston-natural-resources-corp-otc-hnrc-stocks-rally/

Emerging Companies: Key Developments and Investment Insights: RGLS, INBS, VTAK, DYAI, TCBP

https://thestreetreports.com/emerging-companies-key-developments-and-investment-insights-rgls-inbs-vtak-dyai-tcbp/

Lately, several enterprises have surfaced in the media spotlight for various reasons, potentially catching the eye of investors. This article offers an in-depth examination of five companies that could be worthwhile to monitor.

Regulus Therapeutics Inc. (NASDAQ: RGLS) made headlines on March 12, 2024, following its declaration of securing approximately $100 million via a private equity placement to a group comprising accredited and institutional investors. The funding round exceeded expectations, with participation from both fresh and established investors, with plans for completion by March 14, 2024.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) stands out as a prominent medical technology firm renowned for its development of rapid, intelligent, and non-invasive testing solutions. On March 12, 2024, it finalized several securities purchase agreements from March 8, 2024, successfully concluding an offering valued at $10.1 million. With its stock boasting a low reported float, Intelligent Bio Solutions emerges as a compelling entity worth monitoring closely.

Catheter Precision Inc. (NYSE American: VTAK), a U.S.-based medical technology firm, has recently disclosed the deployment of its LockeT product for the first time beyond U.S. borders. This milestone occurred at the Heart Hospital of Hamad Medical Corporation in Doha, Qatar. The company’s VIVO, a non-invasive 3D imaging system aiding physicians in pinpointing the source of arrhythmias, has been gaining significant traction worldwide within the medical communities globally. Consequently, the stock has experienced a noteworthy upward surge in recent times.

Dyadic International Inc. (NASDAQ: DYAI), the biotechnology firm, has recently concluded a private offering worth $6 million. Notably, investors in this offering comprise immediate family members and family trusts associated with Mark Emalfarm, the company’s President and CEO. Among the participants in this private placement is the Francisco Trust, which holds a 5% stake in Dyadic’s outstanding stock.

TC BioPharm Holdings PLC (NASDAQ: TCBP), a clinical-stage biotechnology company, is engaged in advancing platform allogeneic gamma-delta T cell therapies for cancer treatment and other ailments. On February 22, 2024, the company declared that its proposed clinical trial authorization (CTA) had been formally approved by the MHRA. This amendment allows the company to elevate the dosage of gamma delta T-cells.

Appearing on Fox Business Tonight: GEVI, PETV, BTC, BULT, SWISF and more…

https://thestreetreports.com/appearing-on-fox-business-tonight-gevi-petv-btc-bult-swisf-and-more/

New to the Street revealed details regarding corporate interviews scheduled for broadcast on the Fox Business Network on March 11, 2024, at 10:30 PM PT. Here’s a glimpse of the featured companies and what viewers can anticipate.

General Enterprise Ventures Inc. (OTC: GEVI): Steve Conboy, the Chief Technology Officer of the company and its wholly owned subsidiary “Mighty Fire Breaker”, will discuss the company with host Jane King. Mighty Fire Breaker specializes in offering eco-friendly, sustainable solutions aimed at equipping firefighters with efficient wildfire defense strategies. Unlike many products currently available, which are toxic and harmful to wildlife when used to suppress wildfires, Mighty Fire Breaker’s products are environmentally safe. In fact, the San Diego California Fire and Rescue Department has begun utilizing Mighty Fire Breaker products for firefighting purposes.

PetVivo Holdings Inc. (NASDAQ: PETV) will be showcased in the ‘Game Changers’ segment of the program. The Chief Executive Officer and President of PetVivo Holdings Inc. will engage in conversation with host Ana Berry. PetVivo Holdings earned its spot in the Game Changers segment due to its groundbreaking work in developing innovative therapeutic medical products for pets. Owners of horses, cats, and dogs have witnessed remarkable outcomes through the utilization of the company’s SPRYNG with OsteoCushion Technology. This technology involves an injectable intra-articular veterinary medical device featuring cellular matrix micro-particles. Many veterinarians have opted for this technology over surgeries, assisting pet owners in managing joint-related issues effectively.

The recent surge in the price of Bitcoin, (BTC) exceeding $70,000 today, is noteworthy in this context. The continuous influx of funds into Bitcoin ETFs has been identified as a major factor driving the cryptocurrency to its record highs recently. The significant focus on Bitcoin has also contributed to substantial gains seen in other cryptocurrencies such as Ethereum, which also reached a record high. Additionally, notable gains have been observed in other cryptocurrencies including Solana, Shiba Inu, and Floki.

Fetch.ai (CRYPTO: FET) will be the second company featured in the Game Changers segment. Humayun Sheikh, the Chief Executive Officer of Fetch.ai, will make an appearance on the segment to deliver an update on the artificial intelligence and tools offered by the company to developers.

Bullet Blockchain Inc. (OTC: BULT) not be featured on the show, but their pioneering SaaS and software development firm stands at the forefront of Bitcoin ATM and blockchain advancements and is important to mention. Recently, Bullet Blockchain Inc. disclosed the successful acquisition of a network of 40 Bitcoin ATM machines in South Florida. This comes after the successful deployment of 10 licensed Bitcoin ATMs across Georgia, marking the initial phase of their planned deployment and branding of 30 additional Bitcoin ATMs. The company emphasized that this acquisition marks a significant advancement in their planned branding development and expansion efforts.

Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR): Alain Ghiai, the Chief Executive Officer of the company, is set to appear in the “Sekur Privacy & Sekur Security Segment: The Weekly Hack” on New to the Street TV. During the segment, Ghiai will discuss a report from the FBI concerning cyberattacks on critical American infrastructure, including the energy grid, by Chinese entities. He will also provide insights into various strategies entities can implement to mitigate such risks.

Rokid: Misa Zhu, the Chief Executive Officer of the company, will also engage in conversation with Jane King, the host of New to the Street. Zhu will discuss Rokid’s Max Pro Smart Glasses, their augmented reality technology platform, and various other augmented reality product offerings during the interview. Notably, one of the major telecom providers in Japan utilizes Rokid’s platform to develop new experiences for their customers.

RushNet (OTC: RSHN) and Royal Caridea Join Forces to Transform Aquaculture Harvesting Shrimp and more…SPZI, HALB, ENZC, HNRC

https://thestreetreports.com/rushnet-otc-rshn-and-royal-caridea-join-forces-to-transform-aquaculture-harvesting-shrimp-and-morespzi-halb-enzc-hnrc/

Numerous companies are anticipated to garner attention this morning following significant announcements made on Thursday, March 7, 2024, making RushNet Inc. (OTC: RSHN) a noteworthy contender for tracking among these others. The company disclosed yesterday the signing of a strategic licensing agreement with Royal Caridea LLC, granting RushNet exclusive rights to deploy Royal Caridea technology in the Canadian and United States markets.

The technology platform accessible to RushNet would equip it with the necessary tools for cultivating aquaculture species such as shrimp worldwide. Notably, this technology offers shrimp farms the benefits of lower production costs, modularity, seamless integration, and straightforward installation processes. The company boasts ownership of over 40 patents across the United States, Europe, and Canada, including US patent numbers 11,206,817 and 11,617,354, as well as Canadian patent number 2973601.

The shrimp farm operators would be able to produce shrimp close to where their customers are on a daily basis. Each of the production systems could easily be scaled up to produce anything between 300,000 pounds and 2 million pounds of shrimp a year.

The production systems feature a completely enclosed design, aimed at preventing heat loss, minimizing facility corrosion, and maintaining robust biosecurity measures. Considering RushNet’s recent agreement, it would be prudent for investors to consider adding the stock to their watchlists.

Spooz Inc. (OTC: SPZI): On February 28th, Spooz Inc. announced that it had received $18,000,000 towards the financing of the Harmony Villa Project located in Kokomo, Indiana. The funding had been provided to the company by the State of Indiana and the City of Kokomo. The company noted that the project would be managed by Rocky H. Singh, who had been newly appointed as a director at the company. Singh would also add another $500000 in the form of investment into the project.

Halberd Corporation (OTC: HALB): The Institutional Animal Care and Use Committee has approved Halberd Corporation’s (OTC PINK:HALB) testing protocols for their Traumatic Brain Injury (TBI) mitigating nasal spray at Mississippi State University (MSU). Dr. Russell Carr, the Primary Investigator, has commenced preparations for extending the successful Phase #1 pilot test program, which showed compelling results last year. The advanced program is set to launch soon, with several federal agencies expressing keen interest in its progress.

Enzolytics Inc. (OTC: ENZC) In January 2024, the company announced its partnership with the Khapley AI Lab. This collaboration aims to enhance organ longevity, recovery, and the study of aging by integrating artificial intelligence with drug development.

Houston Natural Resources Corporation (OTC: HNRC): The oil and gas firm announced that it had made a move into the digital economy. Houston Natural Resources Corporation revealed that it had been successful in endorsing the transformation of its stake in Cunningham Mining into an innovative digital asset token bringing the power of digital technology to the mining industry.

Market Momentum: Analyzing Five Stocks Exhibiting Strong Upward Trends: INBS, MEDS, IFBD, AISP, VTAK

https://thestreetreports.com/market-momentum-analyzing-five-stocks-exhibiting-strong-upward-trends-inbs-meds-ifbd-aisp-vtak/

Investors are inclined to prioritize stocks exhibiting notable upward momentum. Following a consolidation period, the trend resumed its upward trajectory, initiating another upswing trend.This article will examine five such stocks currently trending higher.

Intelligent Bio Solutions Inc. (NASDAQ: INBS): Recognized as a frontrunner in innovative medical technology, Intelligent Bio Solutions Inc. has garnered notable short-term attention. The company reported robust fiscal second-quarter and six-month results, concluding on December 31, 2023, showcasing a remarkable year-on-year revenue surge of 337% for the six-month period and 114% for the second fiscal quarter. This stellar performance is attributed to the increasing adoption of the company’s Intelligent Fingerprinting Drug Screening System.

Closing the week at $5.57 on Friday, March 1, 2024, the company’s stock has recently shown stability in the mid-$5 range, exhibiting its narrowest trading range in seven sessions. Furthermore, a bullish swing setup has emerged, largely driven by short covering. This development warrants close observation.

TRxADE HEALTH Inc. (NASDAQ: MEDS): On March 6, the stock surged significantly, recording gains of 115% amid considerable investor interest. TRxADE HEALTH Inc. gained prominence following its announcement that the board of directors had approved a special cash dividend of $8 per share of common stock. This special dividend would be funded from a portion of the proceeds derived from the sale of its web-based market platform entities. Scheduled for payment on March 22, 2024, the dividend will be distributed to all TRxADE HEALTH shareholders recorded as of March 18, 2024.

Infobird Co., Ltd. (NASDAQ: IFBD): specializes in delivering software as a service (SaaS) solution powered by artificial intelligence for customer engagement. On March 6, Infobird Co. Ltd. saw its stock surge by 46%. The company previously announced on February 26 that it had opted to revise the effective date of its reverse stock split to March 4, 2024. The press release highlighted that trading of the stock on a split-adjusted basis would commence upon the market’s opening on that date. This delay was attributed to unforeseen challenges in obtaining specific regulatory approvals.

Airship AI Holdings Inc. (NASDAQ: AISP): is a prominent figure in the realm of artificial intelligence-driven data management, sensor technology, and video surveillance solutions. On March 6, the stock of Airship AI Holdings Inc. attracted attention as it surged by 40%. The preceding day, the company revealed the acquisition of a significant contract with an agency within the Department of Justice. This contract pertains to the utilization of the Acropolis Enterprise Sensor Management platform, a video and data management solution developed by the company.

Catheter Precision Inc (NYSE American: VTAK): The company has made significant advancements in the medical technology sector with its innovative products. A standout among these is Catheter Precision Inc.’s flagship product, VIVO, which has revolutionized cardiac procedures. HC21, a UK distributor, has administered 165 procedures using VIVO, generating $1500 in revenue for each procedure with a gross margin of 90%. VIVO, a non-invasive device for detecting cardiac arrhythmias before heart procedures, remains a cornerstone product for the company. Other distributors, hospitals, medical facilities, and similar entities conducting VIVO procedures will also be disclosing their findings.

Catheter Precision, Inc. (NYSE American: VTAK) is approaching its 200-day moving average (DMA) and a breakout point at $0.59, maintaining a consistent trading pattern above both its 20 and 50 DMAs. The convergence of multiple bullish indicators, alongside a robust upward trend, suggests that surpassing the $0.59 threshold could trigger another upward trend for the stock.

Biotech Breakthroughs: $DYAI Dyadic International (NASDAQ: DYAI) Partners with Rabian BV to Combat Rabies
https://thestreetreports.com/biotech-breakthroughs-dyadic-international-nasdaq-dyai-partners-with-rabian-bv-to-combat-rabies/

$INBS Small Float Stocks, Poised for a Break-Out
https://247marketnews.com/small-float-stocks-poised-for-a-break-out/

Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI

In the past few days, a number of companies have come on the radar of investors for a range of reasons. This feature would provide you with a closer look into several of those companies a bit more closely.

Dyadic International Inc. (NASDAQ: DYAI) experienced significant movement in its stock last week, with trading volumes surpassing the average and reaching a six-month high. The company specializes in advanced microbial platforms for protein development and bioproduction to address clinical needs. On February 21, 2024, it was revealed that Dyadic extended its partnership with the Israel Institute for Biological Research (IIBR) and its affiliate, Life Sciences Research Israel (LSRI), to develop solutions for emerging diseases. Earlier in February 2024, Dyadic garnered attention for its partnership with Cygnus Technologies, a division of Maravai LifeSciences (NASDAQ: MRVI) and on Friday, February 23, 2024, Maravai LifeSciences (NASDAQ: MRVI) surged by 63.6%, gaining $3.25 to close at $8.36.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) operates within the medical technology sector, specializing in the provision of rapid, non-invasive drug testing solutions among other early detection health screeners. On February 16, 2024, the company announced that it had received a notification from NASDAQ’s Listing Qualifications Department on February 13, 2024. This notification confirmed that Intelligent Bio Solutions Inc. had regained compliance with NASDAQ Listing Rule 5550(a)(2), which requires the maintenance of a minimum bid price of $1 per share for its common stock. Subsequently, on February 20, 2024, significant short interest was detected by Stock Scanners, leading to the initiation of short covering observed as of Thursday, February 22, 2024, at 2:35 pm EST. This marked the beginning of an upside reversal, with the intraday peak for February 2024 recorded at $11.70.

Catheter Precision Inc. (NYSEAMERICAN: VTAK) is a pioneering technology firm specializing in advanced electrophysiology techniques for the treatment of cardiac arrhythmias. Recently, Catheter Precision Inc. participated in the AF Symposium conference held from February 1-3, 2024 in Boston, Massachusetts, hosted at the Omni Seaport Hotel. The company disclosed on January 25, 2024, its successful procurement of a new distributor for its VIVO product tailored for the Turkish market. Furthermore, on January 22, 2024, Catheter Precision announced a distribution agreement for its LockeT product in Brazil with another distributor.

Redwood Scientific Technologies Inc. (OTC: RSCI) experienced a notable surge in its stock performance over the past week, with gains reaching an impressive 119%. Trading volume for the stock also demonstrated considerable strength. On February 6, 2024, it was revealed that Redwood Scientific Technologies Inc. had entered a partnership with Jeeva Clinical Trials. This collaboration is geared towards initiating clinical effectiveness studies for Redwood Scientific Technologies’ TBX-free oral strips, designed to aid in smoking and e-cigarette cessation efforts.

Venus Concept Inc. (NASDAQ: VERO), a leading global medical aesthetic technology firm, disclosed on February 22, 2024, that it had obtained the CE Mark from DEKRA Certification BV. This certification grants Venus Concept Inc. the authorization to distribute its Venus Versa Pro system within the European Union market. Furthermore, on November 1, 2023, the company announced the commencement of commercial sales for the product in the United States.

Nasdaq Stocks Are Taking Center Stage This Week! $DYAI, $MRVI, $SPWR, $VTAK, $KAVL, $INBS

https://thestreetreports.com/nasdaq-stocks-are-taking-center-stage-this-week-dyai-mrvi-spwr-vtak-kavl-inbs/

The NASDAQ stands as one of the largest stock exchanges globally, attracting significant attention from investors worldwide. This feature offers a brief overview of five stocks listed on the NASDAQ that garnered attention throughout the week.

Dyadic International Inc. (NASDAQ: DYAI) gained attention on February 14, 2024, following its announcement of a collaboration with Cygnus Technologies, a division of Maravai LifeSciences (NASDAQ: MRVI). Under the agreement, Dyadic International Inc. would partner to quantify host cell proteins extracted from the patented C1-cell filamentous fungus Thermothelomyces heterothallica. It was further highlighted that, in accordance with the agreement terms, Cygnus had also formulated the C1 HCP ELISA Kit, which would be accessible for both Dyadic International and Cygnus. The news release emphasized the critical role of HCP (host cell proteins) in ensuring quality control throughout the biopharmaceutical development process.

SunPower Corp. (NASDAQ: SPWR) made headlines on February 15, 2024, as it unveiled its financial results for the fourth fiscal quarter. The company reported a loss of $123.9 million, equivalent to 71 cents per share. However, after adjusting for one-time expenses and gains, the loss amounted to $1 per share. SunPower Corp.’s performance fell short of analysts’ forecasts, with the average estimate of projections from 10 analysts, as per Zacks Investment Research, standing at 27 cents per share.

Catheter Precision Inc. (NYSEAMERICAN: VTAK) is a pioneering technology firm dedicated to advancing technology for electrophysiological procedures aimed at treating cardiac arrhythmias. On January 25, 2024, the company revealed the appointment of a new distributor for the Turkish territory for its VIVO 3D mapping system, along with a new distributor for its LockeT product in Brazil. Additional expansion announcements are anticipated throughout 2024.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL), the sole distributor of all products manufactured by BIDI Vapor LLC, issued a business update on February 14, 2024. The update, conveyed through a letter from President, Executive Chairman, and Interim Chief Executive Officer Barry M. Hopkins, highlighted significant transitions at Kaival Brands Innovations Group Inc. since the conclusion of its fiscal year on October 31, 2023. Hopkins noted the implementation of new management and board members, alongside notable strides in augmenting sales.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology firm specializing in offering rapid, intelligent, and non-invasive testing solutions. Recently, the company disclosed its anticipated unaudited revenues for the six-month period ending on December 31, 2023, projected at $1.56 million. This marks a significant year-on-year increase of 337%. Furthermore, Intelligent Bio Solutions Inc. announced an anticipated 114% year-over-year rise in unaudited revenues for the second fiscal quarter. These optimistic forecasts are attributed to the growing awareness surrounding the company’s flagship product, the Intelligent Fingerprinting Drug Screening System.

Breaking: Top OTC Stocks Making Headlines This Week! HNRC, SNNC, HALB, GEVI, PBIO


https://thestreetreports.com/breaking-top-otc-stocks-making-headlines-this-week-hnrc-snnc-halb-gevi-pbio/

As the trading week wraps up, it might be opportune for investors to delve into stocks on the OTC markets that garnered attention among traders. Here are five stocks worth monitoring.

Houston Natural Resources Corporation (OTC: HNRC), renowned for its operations in the oil and natural gas sectors, unveiled a significant development this week regarding its strategic pivot towards the digital economy. On February 14, 2024, the company announced the successful conversion of its 9% stake in Cunningham Mining into a digital asset token. This innovative initiative positions the company to potentially revolutionize the mining sector through digital technology. The announcement highlighted that the prominent mining site, Nugget Trap Placer Claim, would undergo a transformative journey into the digital realm.

Sibannac Inc. (OTC: SNNC), a Nevada-based corporation, garnered attention on February 15, 2024, with a significant shareholder update. The company revealed its intention to provide an update following the enthusiastic response to its campus community launch. Sibannac Inc. highlighted the considerable interest from various parties regarding the involvement of The Campus Community in their brand development as part of the spin-off initiative.

Halberd Corporation (OTC: HALB) gained attention on February 8, 2024, following its announcement regarding the approval of testing protocols for its TBI (traumatic brain injury)-mitigating nasal spray at Mississippi State University. The Institutional Animal Care and Use Committee granted the approval. Additionally, Halberd Corporation stated in the news release that Dr. Russell Carr, the primary investigator, had commenced preparations to expand the Phase 1 pilot test program, which had concluded with positive results last year. And on February 6, 2024, that its executives, along with those from Athena GTX, were interviewed by ‘The Street Reports’. The interview primarily centered on the collaboration between the two companies to propel groundbreaking technologies for government contracts. Listen Now!

General Enterprise Ventures Inc. (OTC: GEVI) made a notable announcement on February 14, 2024, regarding its subsidiary, Mighty Fire Breaker. The company revealed that San Diego Fire Rescue (SDFR) would begin utilizing the Mighty Fire Breaker MFB 31 CitroTech to address the ongoing wildfire threat. Concerns and threats related to wildfires among SDFR personnel were highlighted. The product’s accreditations facilitated SDFR’s decision to adopt it.

Pressure BioSciences Inc. (OTC: PBIO) is renowned for its efforts in developing high-pressure-based instruments applicable across various industries. On February 15, 2024, the company disclosed its achievement in centralizing operations within the Boston area. This consolidation enabled the company to seamlessly bring together all personnel into a state-of-the-art facility tailored for advanced research and development, formulation services, and advanced equipment development and production. Furthermore, the facility was designated for contract manufacturing utilizing Pressure BioSciences’ Ultra Shear Technology platform.

$UCLE 5 CENT STOCK MAY HAVE 5 GAME-CHANGING TECHNOLOGIES

https://richardacavalli.wixsite.com/greenplanetmicrocaps/5-game-changing-techs

U.S. Nuclear Is Advancing 5 Super Technologies that Can Help Our Planet and Save Lives
Fossil fuel provides the lion’s share of energy, but it is responsible for global climate change. U.S. Nuclear made early investments in what is now the proving to be the unrivaled leader in clean and safe thermonuclear fusion energy.



Desalination is the best-known way to get drinking water from the oceans, but current reverse osmosis technology costs too much to process. U.S. Nuclear is developing an impressive lower-cost, scalable, desalination technology.



PFAS, commonly found in drinking water, is known as the “Contaminant of the Century” and is so deadly that the EPA is restricting limits to 4 parts per trillion. There is no known detection system available from any provider except . . . U.S. Nuclear developed a real-time desktop sized PFAS monitoring device that can detect PFAS down to 1 part per trillion and expects 2024 commercial launch.



Radioisotopes are required for advanced medical and industrial imaging and cancer therapy but are mostly produced in 4 outdated and unreliable fission nuclear reactors. Cost is high and production is unreliable and inadequate to meet demand. U.S. Nuclear invested in MIFTI/MIFTEC radioisotope generators that will be able to supply multi-billion-dollar quantities at half the current cost.



Capacitors store static electric energy and are used in almost every electronic application. U.S. Nuclear owns 40% of Grapheton that has developed a new generation capacitor that is 3 million times more powerful than today’s super capacitors. This new capacitor is expected to have several applications to replace many batteries and to further miniaturize almost all electronics.



U.S. Nuclear has a total market cap of under $2 million and a share price close to 5 cents. If just one of these technologies succeeds, the impact to U.S. Nuclear shares could be quite meaningful.

“Exploring Market Opportunities Stocks to Watch Under 5¢ Now: $CLNV, $ENZC, $HNRC, $HALB, $SPZI ”

https://thestreetreports.com/exploring-market-opportunities-stocks-to-watch-under-5%c2%a2-now-clnv-enzc-hnrc-halb-spzi/

Investors have the potential to discover significant value by categorizing stocks and exploring various options. For example, there are stocks currently trading below 5 cents that might be worth monitoring. Let’s take a brief glance at five such stocks.

Clean Vision Corporation (OTCQB: CLNV), an emerging player in the realms of innovative clean fuel development and plastic recycling, has revealed the initiation of its Green Bond Offering on January 23. The offering, executed through its subsidiary unit, Clean Seas Partners UK Limited, is anticipated to generate up to $340 million if fully subscribed. The company intends to utilize the raised funds to support projects in Georgia, Atlanta, Morocco, and West Virginia.

Enzolytics Inc. (OTC: ENZC) recently announced a collaboration with Khapley AI Lab on January 16. Under the terms of this partnership, Enzolytics Inc. is set to collaborate with Khapley AI Lab to enhance organ recovery, delve into the science of aging, and extend longevity. The approach involves a synergy of artificial intelligence and drug development. This partnership is recognized as a significant stride in the biotech sector, contributing to the advancement of biology related to organ regeneration and aging.

Houston Natural Resources Corporation (OTC: HNRC) recently presented key highlights for 2024, revealing plans to rebrand as Cunningham Natural Resources Corporation. Beyond its traditional focus on oil and natural gas, the company expressed interest in energy transition materials such as copper, gold, lithium, and other rare earth metals. Emphasizing sustainability, the company aims to broaden its focus beyond conventional oil and gas interests.

Halberd Corporation (OTC: HALB) gained attention on January 11, revealing successful achievement of significant business objectives in the latter half of 2023. The company detailed the accomplishment of various key goals during that period. Notably, Halberd Corporation has been actively engaged in research activities, evident from the update it recently shared.

Spooz Inc. (OTC: SPZI) The stock has undergone notable fluctuations in its shares during recent trading sessions. Following a surge exceeding 1200% in the last month, it has now pulled back, displaying a month-to-date increase of around 600%. Additionally, the stock achieved a new 52-week high at $0.0121. In a notable development last week, the company revealed the acquisition of CIG International (CIG) as its fully owned subsidiary. This strategic move through CIG has enabled JP 3E Holdings to establish a presence with the US Department of Homeland Security and the US Citizenship and Immigration Services.

$DYAI Dyadic International, Inc Invites You to Join Us at The Microcap Conference
https://www.newsfilecorp.com/release/194733/Dyadic-International-Inc-Invites-You-to-Join-Us-at-The-Microcap-Conference

$INBS DGP Plc Takes Drug Testing In-house with Fingerprint Sweat-based Testing
https://www.globenewswire.com/news-release/2024/01/22/2813038/0/en/DGP-Plc-Takes-Drug-Testing-In-house-with-Fingerprint-Sweat-based-Testing.html

$XRTX XORTX Announces $2 Million Public Offering
https://finance.yahoo.com/news/xortx-announces-2-million-public-120000430.html

$CBDW 1606 Corp. Signs Second Major ISO Partnership with CannaSite, a Top CBD Web Developer to Market AI Merchandising Chatbots by 1606.
https://www.prnewswire.com/news-releases/1606-corp-signs-second-major-iso-partnership-with-cannasite-a-top-cbd-web-developer-to-market-ai-merchandising-chatbots-by-1606-302037783.html

$GMER Good Gaming Inc. Announces Official Launch Date for Galactic Acres™ Its First Groundbreaking Mobile App Game Enhanced with Web3 Technology
https://www.globenewswire.com/news-release/2024/01/18/2811541/0/en/Good-Gaming-Inc-Announces-Official-Launch-Date-for-Galactic-Acres-Its-First-Groundbreaking-Mobile-App-Game-Enhanced-with-Web3-Technology.html

“Latest Buzz on The Street: Noteworthy Developments at $DYAI, $ELEV, $ATRA, $ESPR, $KAVL”

https://thestreetreports.com/latest-buzz-on-the-street-noteworthy-developments-at-dyai-elev-atra-espr-kavl/

Lately, several exceptionally innovative companies have gained prominence for their outstanding achievements. This feature will delve into four such companies.

Dyadic International Inc. (NASDAQ: DYAI): Recognized as a leading innovator in the biotech sector, Dyadic International Inc. is extensively engaged in the production of advanced proteins to enhance health, wellness, and nutrition. The company is renowned for its groundbreaking work on the C1 platform, a proprietary fungal expression system capable of generating multiple recombinant proteins. What sets the C1 platform apart is its ability to match the efficiency and output of conventional platforms while achieving this at reduced costs, faster rates, and higher productivity. Dyadic International accomplished this breakthrough by introducing a highly flexible production scale.

The successful commercialization of the C1 Platform across various industrial applications is another accomplishment for the company. Dyadic International is actively progressing through the development stage to achieve the production of commercial-grade proteins. Zacks Small Cap Research has expressed expectations of increased research and development revenues due to the addition of more clients adopting the C1 Platform as research partners.

A pivotal aspect of the company’s operations lies in its ability to yield higher outputs at reduced costs. Additionally, Dyadic has the potential to generate additional revenues by licensing the platform to produce recombinant proteins.

Elevation Oncology Inc. (NASDAQ: ELEV) stands out as a pioneering oncology company dedicated to developing and discovering specific cancer therapies for patients grappling with solid tumors that present significant unmet needs. On January 5, Elevation Oncology Inc. unveiled upcoming milestones for 2024 along with program updates.

The company highlighted its commitment to leveraging its expertise in oncology drug development and antibody-drug conjugates (ADC) to create targeted and innovative cancer therapies for millions of patients. Additionally, Elevation Oncology revealed plans to expand its development program to fully tap into the potential of anti-Claudin 18.2. Progress was also reported in the company’s program focused on targeting HER3 with ADC, with expectations of having a development candidate in place by the end of 2024.

Atara Biotherapeutics Inc. (NASDAQ: ATRA), a leading figure in T-Cell immunotherapy, is actively utilizing its distinctive allogeneic Epstein-Barr virus T-Cell platform to pioneer therapies for cancer and autoimmune diseases. On January 8, Atara Biotherapeutics Inc. disclosed its entry into a definitive agreement regarding the issuance and subsequent sale of pre-funded warrants, enabling the acquisition of 27,272,727 shares of its common stock.

Each pre-funded warrant would be priced at $0.55 per share, and the transaction is set to occur through a registered direct offering to entities affiliated with an existing institutional investor in the company. Notably, these pre-funded warrants carry an exercise price of $0.0001 per share, allowing the holder to exercise them immediately upon issuance.

Esperion Therapeutics Inc. (NASDAQ: ESPR) revealed on January 3, 2024, that a $125 million amendment had been made to its collaboration with Daiichi Sankyo Europe GmbH (DSE), the European headquarters of Daiichi Sankyo Co. Ltd., a Japanese pharmaceutical entity.

The news release from Esperion Therapeutics Inc. highlighted that the amendment not only encompassed a resolution of the dispute between the two entities but also included adjustments aimed at enhancing the long-term valuation of the products. As part of the amendment, DSE is set to make a payment of $100 million to Esperion Therapeutics Inc. in mid-January 2024, predating the anticipated Type II(a) variation approval for NILEMDO and NUSTENDI Tablet by the European Medicines Agency.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) The company stands to potentially gain substantially from the FDA’s efforts to regulate non-compliant and unauthorized e-cigarette products. As the exclusive distributor of BIDI Vapor LLC’s products, including the BIDI Stick e-cigarette, in the United States, Kaival Brands Innovations Group Inc. announced in November its commitment to full compliance with all FDA regulations. Additionally, the company took proactive measures to address concerns related to youth vaping.

“Market Movers: Stocks in the Spotlight: $INBS, $LAES, $NVAX, $LUMN, $VTAK”

https://thestreetreports.com/market-movers-stocks-in-the-spotlight-inbs-laes-nvax-lumn-vtak/

Lately, there has been significant attention on healthcare, technology, and medical technology firms. This article aims to offer a detailed exploration of five such companies that have recently garnered considerable focus.

Operating in the medical technology sector, Intelligent Bio Solutions Inc. (NASDAQ: INBS) specializes in delivering rapid, innovative, and non-invasive testing solutions. The company claims that its Intelligent Fingerprinting Drug Screening System has the potential to revolutionize portable testing through the analysis of fingerprint sweat. Moreover, the system can be applied in various other fields beyond drug screening applications.

The company disclosed on December 19, 2023, that its Intelligent Fingerprinting Drug Screening System achieved accreditation from the National Association of Testing Authorities (NATA). This accreditation, widely acknowledged both nationally and globally, serves as a significant means of endorsing and acknowledging the capabilities of organizations engaged in specialized scientific and technical pursuits.

The accreditation process adheres to rigorous standards in line with ISO guidelines. This accreditation is instrumental in aligning the company with crucial global standards, addressing compliance, risk, and quality matters. Essentially, it not only enhances Intelligent Bio Solutions’ standing in the market but also bolsters its business operations.

Now, the acknowledgment of the accreditation award as a significant milestone for the company underscores the dedicated efforts of its team. Furthermore, it is expected that this development will open new avenues for the company, both in the domestic and international markets, as their Intelligent Fingerprinting Drug Screening System becomes accessible to a wide range of industries and companies.

SEALSQ Corp. (NASDAQ: LAES) is a prominent figure in the PKI, semiconductor, and post-quantum technology development sectors. On January 11, the company revealed the successful completion of the second tranche of its private placement, totalling $10 million. This private placement, a segment of a larger $20 million placement by the company, marks a significant development for SEALSQ Corp.

In adherence to the securities purchase agreement inked with a consortium of institutional investors on July 11, 2023, SEALSQ Corp. executed the private placement. The company clarified in its news release that the repayment of the initial $10 million tranche associated with the securities purchase agreement had been accomplished through the issuance of ordinary shares in SEALSQ Corp.

Novavax Inc. (NASDAQ: NVAX) A globally recognized entity, Novavax Inc. is engaged in the creation of protein-based vaccines utilizing its Matrix-M adjuvant. The company made a significant announcement on December 18, 2023, stating that its product, the Nuvaxovid XBB 1.5 dispersion for injection COVID-19 vaccine, received emergency use authorization from the Taiwan Food and Drug Administration.

The approval was granted for an active immunization initiative targeting individuals aged 12 and above to prevent COVID-19 infection. Novavax Inc. disclosed that the vaccine doses would be supplied to Taiwan in accordance with an existing advanced purchase agreement. Subsequently, the vaccine would be accessible at various vaccination centers throughout Taiwan. The company emphasized its close collaboration with Taiwanese authorities to ensure the widespread availability of the updated product across the country.

Lumen Technologies (NYSE: LUMN) made headlines on January 9, 2023, as reports indicated the company was in talks to garner support for a debt arrangement. This debt deal aimed to extend the maturities on significant debt amounts, totalling billions of dollars, and facilitate the raising of fresh capital.

In 2023, the telecommunications firm reached an agreement on a debt restructuring deal with several creditors holding a combined debt exceeding $7 billion. Under the terms of the restructuring, Lumen Technologies secured an extension on its debt maturities. Additionally, these creditors provided the company with $1.2 billion in funding through long-term debt.

Catheter Precision Inc. (NYSE American: VTAK) garnered attention in a feature within “MedTech Outlook” as a standout innovator in the rapidly expanding field of medical manufacturing. Specializing in electrophysiology (EP) technology. Also, this week they announced 4Q, 2023 annual Financials and the Board Authorizes its CEO and Chairman to Make “Open Market” Purchases of Company Shares. Explore the full interview in “MedTech Outlook” for comprehensive insights.

Bitcoin (BTC) Surge Fuels Interest in Bitcoin-Related Stocks: $BULT, $WULF, $BTBT, $INBS

https://thestreetreports.com/bitcoin-btc-surge-fuels-interest-in-bitcoin-related-stocks-bult-wulf-btbt-inbs/

Bullet Blockchain Inc. (OTC: BULT) stands as a trailblazer in the realms of SaaS and software development within the blockchain and Bitcoin ATM machine technology sectors. On January 9, 2024, the company disclosed the successful acquisition of a network comprising up to 40 Bitcoin ATMs located in South Florida. This achievement is deemed a significant milestone for Bullet Blockchain Inc., as the network is slated to play a pivotal role in the company’s upcoming phase of deployment and branding.

This transaction forms a crucial component of the company’s extensive expansion strategy, showcasing Bullet Blockchain’s relentless commitment to being key innovators in the dynamic realm of digital currencies. With South Florida being a pivotal market in the digital asset industry and a significant element of the company’s overarching growth strategy, this move reflects Bullet Blockchain’s dedication to strategic development. Post-acquisition, the company has successfully broadened its presence to encompass two states.

TeraWulf Inc. (NASDAQ: WULF) is the proprietor and operator of several vertically integrated Bitcoin mining facilities within the United States. These facilities, under TeraWulf Inc.’s management, are fueled by an impressive 91% of zero-carbon energy. In a significant development on January 12, 2024, the company revealed the appointment of two new directors to its board: Christopher Jarvis and Amanda Fabiano.

Jarvis brings over four decades of leadership experience in cybersecurity, with a strong background in both the public and private sectors. On the other hand, Fabiano is a recognized leader in the Bitcoin mining industry, boasting significant operational and strategic expertise. These appointments by the company come in the aftermath of Jason New’s recent resignation from the board. Effective January 12, 2024, the addition of Jarvis and Fabiano expands TeraWulf’s board to include 10 directors, with six of them being independent.

Bit Digital Inc. (NASDAQ: BTBT) runs a sustainable platform focusing on artificial intelligence (AI) and digital assets. On January 10, the company revealed an expansion of the contract scope in its initial engagement with a customer for the Bit Digital AI business.

Under the terms of the newly established contract, the company is tasked with providing the client with computational power from an additional 512 GPUs for a duration of up to three years. The overall contract involves the provision of 2048 GPUs, translating to annualized revenues amounting to $50 million for Bit Digital. To meet the contract requirements, the company has initiated a purchase order for 64 servers manufactured by Super Micro Computer Inc.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) the medical technology firm announced a noteworthy achievement as its Intelligent Fingerprinting Drug Screening Solution received accreditation from the National Association of Testing Authorities (NATA). This accreditation holds significance for the company, considering its recognition both in the United States and internationally. Notably, the accreditation process adheres to stringent standards, meeting the criteria set by ISO.

“The Week’s Stock Market Highlights: $VTAK, $HNRC, $CLNV, $HALB, $SPZI

https://thestreetreports.com/the-weeks-stock-market-highlights-vtak-hnrc-clnv-halb-spzi/

The trading week is going to come to a close today, but there have been a number of major moves that may have caught the eye of plenty of investors. Many companies made major announcements throughout the course of the week, and it may be a good idea for investors to take a look into the selected ones. This feature provides you with a look at five such companies.

Catheter Precision Inc. (NYSE American: VTAK) garnered attention in a feature within “MedTech Outlook” as a standout innovator in the rapidly expanding field of medical manufacturing. Specializing in electrophysiology (EP) technology. Also, this week they announced 4Q, 2023 annual Financials and the Board Authorizes its CEO and Chairman to Make “Open Market” Purchases of Company Shares. Explore the full interview in “MedTech Outlook” for comprehensive insights.

Houston Natural Resources Corp. (OTC:HNRC) On January 10, the company outlined an investor presentation for 2024 with a pending name, symbol and CUSIP change, to Cunningham Natural Resources Corp, outlined an investor presentation for 2024. Here is the presentation

On January 3, the company entered the news cycle after providing shareholders with updates about its latest business developments. Houston Natural Resources Corp. announced that it had filed a filing with FINRA to change its name to Cunningham Natural Resources Corp. as well as make changes to its CUSIP number and ticker symbol.

The decision by the company was made in light of its 100% acquisition of Cunningham Energy LLC. The acquisition also boosted Houston Natural Resources Corp.’s net asset value to $1.70 per share.

Clean Vision Corporation (OTCQB:CLNV)—the circular economy player—is an emerging power in the clean fuel development and plastic recycling space. On January 8, Clean Vision Corporation announced that its subsidiary unit, Clean Seas Partners UK Ltd, had been awarded an ESG (Environmental, Social, and Governance) SPO (Second Party Opinion) by the International Shareholder Services (ISS) pertaining to its green bond offering. It was deemed another successful step towards completing the green bond offering.

Halberd Corporation (OTC:HALB) The company’s stock has been on fire since January 1 and has managed to clock gains of 71.43% since then. On January 10, Halberd Corporation announced that it had inked a profitable revenue-sharing agreement with the privately held Athena GTX Inc. Athena GTX is focused on providing medical care solutions meant for use by first responders in both the private and government sectors.

Spooz Inc. (OTC:SPZI) The stock was in sharp focus yesterday as it continued on its upward surge and took its gains in the past 30 trading days to as much as 1000%. Spooz Inc.’s fully owned subsidiary unit, JP Energy Global PTE LTD, was in focus on January 5 after it announced that it had executed as many as nine commodity contracts for Grade A Chicken Paws with a total value of $303 million. The value included previous commodity contracts announced in December 2023.

“Revolutionizing Biotechnology: Dyadic International (NASDAQ: $DYAI ) Leads with C1 Platform for Swift and Efficient Protein Production”

https://thestreetreports.com/revolutionizing-biotechnology-dyadic-international-nasdaq-dyai-leads-with-c1-platform-for-swift-and-efficient-protein-production/

The company is known for being one of the more innovative operators in the biotechnology space. Dyadic International (NASDAQ: DYAI) is working on the next generation of proteins so as to boost wellness, nutrition, and health. The company is credited with having developed the C1 platform, a proprietary fungal expression system that can help in the production of a range of recombinant proteins.

The platforms are known for providing the same output and efficiency as traditional platforms; however, they provide those benefits quicker, at a lower cost, and at higher levels of productivity. The company has managed to accomplish that through a flexible production scale. The process does not involve the use of endotoxins or viral inactivation.

The C1 platform produced the proteins in 12 to 14 days as opposed to CHO cells, which take 41 to 54 days, and baculovirus, which takes 28 to 38 days. C1 has the capability of producing three to four batches during the same time period when CHO or Baculovirus may produce one batch.

Dyadic has been successful in C1 commercialization in a number of industrial applications, and currently the company is working on development so as to produce proteins of commercial grade. The company had sold off its industrial business to DuPont in 2015 for $75 million. The proceeds from the sale had been deployed towards the repurchasing of stock and also for additional development of the C1 platform for biologics production.

Recently, Zacks Small Cap Research stated that there was expectation of growth in research and development revenues owing to the onboarding of more C1 platform research partners.

The company’s USP lies in higher-yield production at lower costs. Additionally, the C1 platform can also be licensed for deployment towards the production of recombinant proteins. The research licenses are already available with the company, and subsequently, production strains could be developed and then licensed. The company is currently in a strong position to provide recombinant serum albumin at a competitive cost.

The company’s mode of operation is fairly simple. Dyadic International’s clients supply it with the target DNA sequence, and within a period of six weeks, the CI platform helps in producing stable cell lines and testing material. The company’s overarching mission is to develop such proteins through its platform, which could have a profound effect on global health. The C1 platform has been responsible for coming up with a large number of potential products already. Additionally, the products may not need to go through human trials prior to commercialization.

Noteworthy Trend Shifts in Stocks: $CLNV, $HALB, $SPZI, $HNRC, $ENZC

https://thestreetreports.com/noteworthy-trend-shifts-in-stocks-clnv-halb-spzi-hnrc-enzc/

As markets are moving towards an all-time high, there are several opportunities in penny stocks, considering both technical and fundamental analysis. Here are 5 companies we have identified based on their recent moves and news developments.

This week, it could be advantageous for investors to delve deeper into Clean Vision (OTCQB: CLNV), a rising contender in the realm of pioneering clean fuel advancements and plastic recycling. The company is committed to propelling the plastic circular economy to new heights.

This Monday, the company garnered attention as it strengthened its dedication to the circular plastic economy, moving a step closer to its green bond offering. In a recent announcement, the company revealed that its subsidiary, Clean Seas Partners UK Limited, received a favorable Environmental, Social, and Governance (ESG)-related second-party opinion (SPO) from International Shareholder Services (ISS) regarding its previously disclosed green bond offering.

The company emphasized that the favorable second-party opinion (SPO) signified Clean Vision’s dedication to ESG standards. Crucially, the SPO issued by ISS endorsed the compliance of Clean Seas UK’s Green Bond with global ESG standards.

Clean Vision (OTCQB: CLNV) has consistently maintained a trading position above its 200-day moving average (DMA), which resides beneath its 50-day DMA. This alignment has resulted in a Golden Cross, a potent bullish indicator indicating an upward trend in the stock or market. Moreover, the stock has been witnessing the same trend as the following stocks have seen.

Halberd Corp. (OTC: HALB) gained momentum on Monday and soared 43.08% on 9X average volume. Importantly, the stock has crossed above its 200-day moving average, improving its long-term outlook by crossing above that critical trendline and developing a strong uptrend.

Enzolytics Inc. (OTCMKTS:ENZC) is another stock that was in focus and closed up 26.6% Monday on 1.5x average volume. Moreover, the stock is rising above its 50-day moving average, crossing above that important trendline, and returning to the uptrend.

Houston Natural Resources Corporation (OTC: HNRC) stock has been in a strong uptrend over the past week and surged 31% on increasing volume. Following a recent rally, the stock has entered a bullish phase, comfortably trading above both the 20- and 50-day moving averages.

On January 3, 2024, the company shared a summary of its recent notable accomplishments and milestones with shareholders. Additionally, it provided insights into its strategic direction for the year 2024 and beyond.

Spooz Inc. (OTC: SPZI) stock has been gaining momentum and went up 113% in 5-day trading sessions. Moreover, the stock made a new 52-week high of $0.0098 in Friday’s trading session.

Last week, the company drew attention as its wholly owned subsidiary, JE Energy Global PTE LTD, made a significant announcement. JE Energy Global revealed the execution of three commodity contracts with a combined value of $36,774,000 for Grade A Chicken Paws.

$XRTX Alliance Global Partners analyst James Molloy maintains XORTX Therapeutics (NASDAQ: XRTX) with a Buy and raises the price target from $9 to $14.
https://www.alsahm.com/news/content/alliance-global-partners-maintains-buy-on-xortx-therapeutics-raises-price-target-to-14-2024-01-04

Stocks Commence 2024 Bullish Rally: $LMDX, $HNRC, $BULT, $HALB, $SPZI

https://thestreetreports.com/stocks-commence-2024-bullish-rally-lmdx-hnrc-bult-halb-spzi/

Several stocks have undergone significant movements in the recent week. It might be beneficial for investors to have a quick overview of these stocks readily available. Let’s take a closer look at them now.

LumiraDx Ltd (NASDAQ: LMDX) has faced persistent downward pressure on its stock throughout the past year, witnessing a nearly 95% year-over-year decline. The stock is currently in an oversold condition, suggesting a potential rebound after the recent decline. In a recent development, the company disclosed the appointment of joint administrators for two of its subsidiaries.

The administrators have concluded a conclusive agreement to sell certain companies within the LumiraDx group, specifically those linked to LumiraDx’s groundbreaking point-of-care technology, to the Swiss pharmaceutical company Roche (OTC: RHHBY).

The Houston Natural Resources Corporation (OTC: HNRC) stock experienced a significant surge on Wednesday, marking a remarkable 27.60% increase and extending its 5-day upward trend to an impressive 68.15%. Notably, the stock achieved four consecutive positive closes with trading volumes surpassing the average. Following a recent rally, the stock has entered a bullish phase, comfortably trading above both the 20- and 50-day moving averages.

On January 3, 2024 the company shared a summary of its recent notable accomplishments and milestones with shareholders. Additionally, it provided insights into its strategic direction for the year 2024 and beyond.

Bullet Blockchain Inc. (OTC: BULT) stock has demonstrated an upward trend in the past week, establishing higher highs and higher lows on the chart. The stock experienced a remarkable surge of 145% in the last five trading sessions and is currently trading well above the 20-day, 50-day, and 200-day moving averages.

On December 18, 2023, the company announced the successful deployment of 10 Bitcoin ATMs across various locations in the state of Georgia. This marked the completion of the initial phase of their planned deployment and the branding of 30 Bitcoin (BTC) ATM kiosks.

Halberd Corporation (OTC: HALB) is currently experiencing a robust uptrend, demonstrating bullish momentum in the stock market. Over the past week, the stock has surged by an impressive 52.12% across five trading sessions, accompanied by above-average trading volume. From a technical perspective, HALB appears to be in a bullish position, trading above both the 20- and 50-day moving averages.

On December 13, 2023, the company disclosed a significant development, entering into an agreement with CrodenHealth.com, based in Canada, for the global distribution of Halberd Corporation’s patented naltrexone low-dose line of products.

Spooz Inc. (OTC: SPZI) experienced substantial gains on Wednesday, surging by more than 29%. Over the course of 5 trading sessions, the stock has witnessed an impressive increase of 76.67%. Notably, the stock achieved a new 52-week high of $0.0057 in the previous session, indicating a potential continuation of the bullish trend.

Last week, the company drew attention as its wholly owned subsidiary, JE Energy Global PTE LTD, made a significant announcement. JE Energy Global revealed the execution of three commodity contracts with a combined value of $36,740,000 for Grade A Chicken Paws.

"Penny Stocks to Watch Under 5¢ Now" $HNRC, $CLNV, $ENZC, $SPZI, $HALB

https://www.marketscreener.com/quote/stock/HOUSTON-NATURAL-RESOURCES-120792563/news/Penny-Stocks-to-Watch-Under-5-Now-HNRC-CLNV-ENZC-SPZI-HALB-45656976/

The penny stocks market continues to generate significant interest among investors as the year approaches its end. Given this scenario, it might be prudent for investors to explore specific undiscovered stocks within this niche. Here's a brief overview of five penny stocks trading below 5 cents per share that could be worth monitoring at this juncture.

Houston Natural Resources Corporation (OTC: HNRC), an oil and natural gas company, has stood out as a compelling player in the industry of late. The company established the SPAC entity known as HNR Acquisition Corp., an independent player in the oil and natural gas sector specializing in the acquisition, development, and exploration of properties in the Permian Basin.

On December 20, 2023, HNR Acquisition Corp. (NYSE: HNRA) gained prominence in search results following the revelation of its appointment of Dante Caravaggio as the new Chief Executive Officer. The official announcement highlighted Caravaggio's impressive executive background, citing his successful track record and previous roles at various large-cap companies.

On December 11, 2023, the company made headlines as its portfolio company, HNR Acquisition Corp. (NYSE: HNRA), completed a business combination on November 15, 2023. Through this transaction, HNR Acquisition Corp. (NYSE: HNRA) acquired all the equity interests in Pogo Resources LLC and its subsidiary, LH Operating LLC, making it an independent oil and natural gas company.

The company is set to engage in the acquisition, development, production, and exploration of oil and gas properties, particularly in the Permian Basin. Additionally, Houston Natural Resources Corporation (OTC: HNRC) owns interests in the Grayburg-Jackson oil field in the Permian Basin.

On November 13, 2023, the company attracted attention by announcing its financial results for the period ending on September 30, 2023. In the nine-month period, the company demonstrated strong performance compared to the same period in 2022. Total revenues for the period reached $15,241,815, marking a 5% year-on-year increase from the $14,462,094 generated in the previous year. Total earnings amounted to $8,871,912, reflecting a 9% year-on-year growth. The earnings per share for the nine-month period were $0.06, indicating a 20% improvement.

Clean Vision Corporation (OTC: CLNV): This emerging force in the $14 Trillion in the green energy and clean technology industry experienced a robust upward trend in its stock over the past week, accumulating gains of 6.21%. On December 5, 2023, the company disclosed the successful trademark approval for its clean hydrogen product, AquaH®, by the United States Patent and Trademark Office. Highlighting the innovation, the company emphasized the technology's capacity to generate carbon-neutral hydrogen, with a focus on utilizing waste plastic as a feedstock.

Enzolytics Inc. (OTC: ENZC) On November 20, 2023, it was revealed that Enzolytics Inc. had submitted a revised OTC Annual Report covering the period concluding on December 31, 2022, along with the overdue disclosure for the period concluding on September 30, 2023. The motivation behind the amendment of Enzolytics Inc.'s annual disclosure was to incorporate the audited financial statements for the periods ending on December 31, 2022, and December 31, 2021.

Spooz Inc. (OTC: SPZI) On December 26, 2023, the spotlight turned to the company following reports that its wholly owned subsidiary, JP Energy Global PTE LTD, had finalized a commodity contract valued at $53.46 million for Grade A Chicken Paws. The news release highlighted that the buyer had officially affirmed the contract on December 15, 2023. Additionally, Spooz subsidiary JP Energy Global issued a performance bond to the buyer, amounting to 2% of the financial operating instrument's total value.

Halberd Corporation (OTC: HALB) On December 13, 2023, the company made headlines following the revelation of a significant accord with the Canada-based CrodenHealth.com. According to the terms of the agreement, CrodenHealth.com is set to manufacture, sell, market, and distribute Halberd Corporation's globally patented low-dose naltrexone combo products. Furthermore, the agreement grants CrodenHealth.com the right of first refusal for the rights to other products within the developmental pipeline of Halberd Corporation.

“2024 Market Outlook: SmallCap Radar Stocks Unveiled”: DYAI, SKYX, QUBT, KNW, VTAK

https://thestreetreports.com/2024-market-outlook-smallcap-radar-stocks-unveiled-dyai-skyx-qubt-knw-vtak/

As the prospect of another new year approaches, a significant number of investors are directing their attention towards potential investment themes within the small-cap sector for 2024. Highlighted at the 12th Annual Benchmark Discovery Conference, held at the New York Athletic Club in December 2023, here are five (5) small-cap stocks noteworthy investment ideas.

Dyadic International Inc. (NASDAQ: DYAI) has garnered attention among institutional investors, with certain stocks being exclusively highlighted. Notably, Dyadic was spotlighted as a top pick at the 12th Annual Benchmark Discovery Conference. This biotech firm is actively engaged in developing a diverse range of products spanning animal health, human health, and alternative proteins. The company is currently leveraging its patented C1 technology in the creation of antibodies and vaccines for various infectious diseases affecting humans. Dyadic is actively working on developing vaccines for other infectious diseases such as influenza and cancer.

Furthermore, Dyadic’s alternative protein initiative is focused on reducing the costs associated with recombinant protein production. Utilizing its Dapibus™ platform and other cutting-edge technologies, the company aims to achieve cost efficiency in producing recombinant non-pharmaceutical proteins. The overarching goal is to advance innovation in the field of protein production.

Remarkably, the stock has experienced a 100% surge in its daily trading volume in the last week. This consolidation may be indicative of a potential shift toward an upward trend, especially when it surpasses its 50-day moving average (DMA).Top of Form

SKYX Platforms Corp. (NASDAQ: SKYX): A pioneering platform technology company, SKYX currently possesses 77 patents globally, with an additional portfolio comprising over 60 home décor and lighting websites. The company’s overarching goal is to enhance the intelligence and safety of buildings and homes.

On December 11, SKYX Platforms Corp. announced the successful renewal of a five-year global licensing master service agreement with GE Technology Development Inc. Under this agreement, the company’s cutting-edge smart technologies will be licensed both in the United States and internationally. The terms of the agreement include provisions for one-year renewals. Notably, the stock has demonstrated a 5% increase in value over the past week.

Know Labs Inc. (NYSEAMERICAN: KNW): This emerging developer of non-invasive medical diagnostic technology unveiled its financial results for the fourth fiscal quarter and the fiscal year concluding on September 30, 2023, on December 19, 2023.

In the 2023 fiscal year, Know Labs Inc. experienced a net loss of $15.29 million, showcasing a notable improvement of 23.8% compared to the net loss of $20.07 million incurred in the 2022 fiscal year. The company reported cash and cash equivalents of $8.02 million at the end of the period, contrasting with $12.59 million at the conclusion of the previous fiscal year. Significantly, the stock has demonstrated a 5% increase in value over the past month.

Catheter Precision, Inc. (NYSE American: VTAK) released its financials and highlights for the Second Quarter of 2023, unveiling total assets amounting to $35.5 million and cash reserves of $7.4 million and revenues for the six-month period ending on June 30, 2023. Catheter Precision, Inc., is a U.S.-based medical device company, offering innovative solutions to enhance the treatment of cardiac arrhythmias. The company collaborates with physicians to develop cutting-edge technology for electrophysiology procedures, and it consistently focuses on enhancing its product offerings.

Recently, the stock has experienced a notable surge in the daily trading volume in recent days. Specifically, during the latter part of December, the trading volume for Catheter Precision Inc. stock increased by approximately 100%.

Quantum Computing Inc. (NASDAQ: QUBT): The technology company specializing in advanced nanophotonics and quantum optics drew attention on November 13 when it disclosed its financial results for the three- and nine-month periods concluding on September 30, 2023.

During the third quarter, Quantum Computing Inc. recorded revenues of $50,000, marking an increase from $38,000 in the same quarter of the previous year and $112,000 in the second quarter of 2023. The cumulative revenues for the first nine months of the year amounted to $283,000, reflecting a notable year-on-year improvement of 111%. It was highlighted that quantum computing had recently entered its commercialization stage. Significantly, the stock has demonstrated a 6% increase in value over the past week.

“Holiday Season Stock Surge: Exploring Potential Opportunities for 2024” $INBS, $VTAK, $KAVL, $CLNV, $BULT

https://thestreetreports.com/holiday-season-stock-surge-exploring-potential-opportunities-for-2024-inbs-vtak-kavl-clnv-bult/

Several stocks have undergone significant movements in the recent week. Considering the holiday season, it might be beneficial for investors to have a quick overview of these stocks readily available. Let’s take a closer look at them.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) has witnessed a robust uptrend in its stock since the previous Monday December 18, 2023, with gains reaching up to 14.7%. On December 19, 2023, the medical technology firm announced a noteworthy achievement as its Intelligent Fingerprinting Drug Screening Solution received accreditation from the National Association of Testing Authorities (NATA). This accreditation holds significance for the company, considering its recognition both in the United States and internationally. Notably, the accreditation process adheres to stringent standards, meeting the criteria set by ISO.

Catheter Precision Inc. (NYSEAMERICAN: VTAK), a U.S.-based medical devices company dedicated to enhancing the lives of patients with cardiac arrhythmias, has experienced a notable surge in the trading volume of its stock in recent days. Specifically, during the latter part of December, the trading volume for Catheter Precision Inc. stock increased by approximately 100%. On December 22, 2023, the company released significant updates related to its performance in the third fiscal quarter. David Jenkins, the Chief Executive Officer, expressed satisfaction with the completion of the Q3 filing and highlighted substantial momentum as the fourth quarter approached.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) observed a surge in trading volume and achieved gains of 18.93% in the past week, attracting significant interest. The company stands to potentially gain substantially from the FDA’s efforts to regulate non-compliant and unauthorized e-cigarette products. As the exclusive distributor of BIDI Vapor LLC’s products, including the BIDI Stick e-cigarette, in the United States, Kaival Brands Innovations Group Inc. announced in November its commitment to full compliance with all FDA regulations. Additionally, the company took proactive measures to address concerns related to youth vaping.

Clean Vision Corporation (OTCQB: CLNV) stands out as a key participant in the realms of clean fuel development and cutting-edge plastic recycling. In a notable development on December 12, 2023, the company disclosed the establishment of Clean Seas Partners UK Limited as its subsidiary. This newly formed subsidiary is tasked with overseeing the initiation of the company’s waste plastic conversion plants in Eastern Europe, the European Union, and Southeast Asia. The creation of this subsidiary not only facilitates the expansion of Clean Vision into these regions but also opens up opportunities for the company to venture into the United Kingdom market.

Bullet Blockchain Inc. (OTC: BULT), a prominent player in Web 3 and blockchain technologies, is recognized as a leading software development company. In a significant update on December 18, 2023, Bullet Blockchain Inc. reported the successful deployment of 10 Bitcoin (BTC) ATM machines in the state of Georgia. This deployment marks the initial phase of the company’s planned rollout, aiming to establish and brand up to 30 Bitcoin (BTC) ATM kiosks.

$BULT Bullet Blockchain Deploys 10 Licensed Bitcoin ATMs
https://www.globenewswire.com/news-release/2023/12/18/2798086/0/en/Bullet-Blockchain-Deploys-10-Licensed-Bitcoin-ATMs.html

$DYAI “Dyadic International Inc. (NASDAQ: DYAI) Advances Biopharmaceutical Innovations and Vaccine Manufacturing Globally”
https://www.digitaljournal.com/pr/news/getnews/-dyadic-international-inc-nasdaq-dyai-advances-biopharmaceutical-innovations-and-vaccine-manufacturing-globally-

"Kaival Brands (NASDAQ: $KAVL ) Strategic Leadership Expansion Positioned for Growth Amid FDA Crackdown on E-Cigarettes"

https://www.marketscreener.com/quote/stock/KAIVAL-BRANDS-INNOVATIONS-111314401/news/Kaival-Brands-NASDAQ-KAVL-Strategic-Leadership-Expansion-Positioned-for-Growth-Amid-FDA-Crackdow-45608343/

As the United States Food and Drug Administration intensifies its crackdown on unauthorized and non-compliant e-cigarette offerings, there is potential for significant gains for Kaival Brands Innovations Group Inc. (NASDAQ: KAVL). The company plays a key role in distributing products from BIDI Vapor LLC, such as the BIDI ® Stick ENDS (electronic nicotine delivery system). All Bidi Vapor products, including the BIDI ® Stick, adhere fully to FDA regulations. Being the exclusive distributor of the BIDI ® Stick in the United States positions Kaival Brands Innovations Group at the forefront of the industry.

On November 7, 2023, the company underscored the initiatives of the United States International Trade Commission (ITC) in addressing unfair sales and import practices within the vaping industry. The company emphasized its acknowledgment of the significance of regulatory measures aimed at ensuring a fair marketplace. It expressed appreciation for the efforts of both the ITC and the FDA in enforcing regulations to safeguard public health. Kaival Brands Innovations Group asserted that it not only ensured compliance with all FDA regulations but also took steps to prevent contributing to the issue of youth vaping.

On November 13, 2023, the company made an announcement regarding the broadening of the responsibilities of its Chairman of the Board, Barry Hopkins, appointing him as the Executive Chairman. According to the company's news release, Hopkins would now function as the principal executive officer of Kaival Brands Innovations Group. It is worth noting that Hopkins assumed the role of Chairman of the Board in March 2023. Kaival Brands disclosed that Hopkins brings extensive experience to the table, with 40 years of involvement in the tobacco industry, showcasing significant operational expertise and a network of industry contacts. With the expansion of his role, Hopkins is set to play a more substantial part in shaping the strategic direction of Kaival Brands Innovations Group Inc. (NASDAQ: KAVL).

The company proceeded with its executive restructuring by naming James W. Dobbins as its general counsel, effective December 5, 2023. It was highlighted that Dobbins brought substantial expertise in offering legal guidance across a wide spectrum of matters for companies. Additionally, the company disclosed that the appointment was anticipated to result in a decrease in legal expenses. Dobbins was expected to contribute to the company's more assertive strategy by providing essential legal counsel.

Significantly, Kaival Brands Innovations Group Inc. (NASDAQ: KAVL). holds an agreement with Philip Morris Products S.A., a wholly owned affiliate of Philip Morris International Inc. (NYSE: PM), concerning the development and distribution of BIDI ® Stick electronic nicotine delivery system ("ENDS") products in global markets. At present, Kaival Brands Innovations Group Inc.'s (NASDAQ: KAVL) stock finds itself in oversold conditions, having recently reached a fresh 52-week low. This indicates a favorable buying opportunity, a potential recovery and a resumption of an upward trajectory. Given these signals, it is advisable to keep a close eye on this stock in the present moment and in the upcoming weeks.

“Bullet Blockchain (OTC: $BULT ) Bolsters Presence, Strategic Acquisition Deploys 10 Bitcoin (BTC) ATMs in Georgia”

https://thestreetreports.com/bullet-blockchain-otc-bult-bolsters-presence-strategic-acquisition-deploys-10-bitcoin-btc-atms-in-georgia/

Bullet Blockchain Inc. (OTC: BULT), a leading software development and SaaS company, is at the forefront of blockchain technologies and the Web 3.0 landscape. On December 18, the company proudly shared its success in installing 10 licensed Bitcoin (BTC)(XBT) ATM machines in Georgia. This achievement marks the initial phase of Bullet Blockchain Inc.’s strategic initiative to establish and deploy a total of 30 Bitcoin ATM kiosks as part of its broader branding efforts.

Bullet Blockchain (OTC: BULT) has successfully finalized a strategic deal involving the acquisition of a portfolio that includes Bitcoin (BTC)(XBT) ATMs. In its official announcement, the company expressed enthusiasm for expanding its cryptocurrency services and enhancing digital asset accessibility for residents of Georgia. The incorporation of the company’s intellectual property portfolio into these Bitcoin (BTC)(XBT) ATMs resulted in the establishment of the first licensed network of Bitcoin ATMs in North America.

Bullet Blockchain (OTC: BULT) stands out as one of the limited publicly traded Bitcoin (BTC)(XBT) ATM companies. The company has achieved success in establishing and introducing Bullet ATMs to meet the increasing demand for this service. Bitcoin (BTC)(XBT), the largest cryptocurrency in terms of market capitalization, continues to surge in popularity as a sought-after asset.

In this context, Bitcoin ATMs offer an uncomplicated avenue for individuals to engage in the expanding cryptocurrency sphere. The opportunity in Atlanta, Georgia, appears significant, given the widespread interest in Bitcoin (BTC)(XBT) among diverse communities in the metropolitan area. The company’s initiative coincided with a period of escalating demand for seamless cryptocurrency transactions.

As stated in its official announcement, the company declared that Bitcoin (BTC)(XBT) ATMs are convenient, user-friendly, and secure, facilitating the purchase and sale of Bitcoin with cash. These transactions typically finalize within minutes, bridging the gap between digital assets and traditional fiat currencies.

Given the ongoing trend of increasing cryptocurrency adoption, Bitcoin (BTC)(XBT) ATMs may be poised for a promising future. The company also emphasized that Bullet ATMs had emerged as the popular option for Bitcoin (BTC)(XBT) transactions. Bullet Blockchain Inc.’s (OTC: BULT) stock has reached a 52-week high of $0.32 and is presently trading at $0.0363, positioning it as a stock to monitor now and in the near future.

“Breaking News This Week Advances, Innovations, Expansion Look Now”: $CLNV, $HNRC, $HALB, $AMYZF, $BULT

https://thestreetreports.com/breaking-news-this-week-advances-innovations-expansion-look-now-clnv-hnrc-halb-amyzf-bult/

As the trading week comes to a close, it could be a good time for investors to look into those stocks that may have hit the news cycle and captured their imaginations. This feature would provide you with a look at five such stocks.

Clean Vision Corporation (OTCQB: CLNV) is a leading player in innovative plastic recycling and the conversion of the same into clean fuel development. On December 12, Clean Vision Corporation announced that it had established a new subsidiary named Clean Seas UK Limited (CS UK).

The company noted in its news release that CS UK had been established with the aim of launching plastic waste conversion facilities in Southeast Asia, the European Union, and Eastern Europe. CS UK would deploy Clean Vision Corporation’s Plastic Conversion Network (PCN) for the purpose of expanding the number of its facilities.

Houston Natural Resources Corp. (OTC:HNRC) On December 11, the oil and natural gas company made a key announcement about HNR Acquisition Corp., its portfolio company. Houston Natural Resources Corp. revealed that on November 15, 2023, HNR Acquisition Corp. had completed a business combination through the purchase of the entire equity interest in Pogo Resources LLC and LH Operating LLC, its subsidiary.

It was also noted that HNR Acquisition Corp. had become an independent oil and natural gas company with interests in the Permian Basin located in New Mexico.

Halberd Corporation (OTC: HALB) On December 13, the company came into focus after it emerged that it had reached an agreement with CrodenHealth.com for the production, marketing, sales, and distribution of its low-dose naltrexone combo products across the world.

The product from Halberd is patented. Additionally, as per the terms of the agreement, CrodenHealth also held the right of first refusal pertaining to similar rights for products that may be produced in the future by Halberd. CrodenHealth enjoys a vast network of relationships in the industry and has dealt with massive pharmaceutical companies in the past.

RecycLiCo Battery Materials Inc. (OTC: AMYZF) The company, a pioneer in the sustainable lithium-ion battery recycling technology space, was in focus on December 14 after it made a key announcement.

RecycLiCo Battery Materials Inc. announced that it had received communication from the European Patent Officer with regards to the possibility of granting the first of the two patent applications from the company. Both patents were related to its innovative lithium-ion battery recycling process.

Bullet Blockchain Inc. (OTC: BULT): The company is involved in innovative software development and SaaS related to blockchain technology and Web 3 spaces. On November 8, Bullet Blockchain Inc. announced that its subsidiary unit, First Bitcoin Capital LLC, had completed its first royalty and patent license agreement with a Bitcoin ATM operating firm.

First Bitcoin also received its first payment following the agreement. Bullet Blockchain introduced a number of licensing programs meant for Bitcoin ATM manufacturing companies. The programs include options like per-transaction licensing fees, partner programs, or revenue sharing.

Recap: $KAVL Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel

https://www.globenewswire.com/news-release/2023/12/07/2792510/0/en/Kaival-Brands-Appoints-James-W-Dobbins-as-Senior-Vice-President-General-Counsel.html

GRANT-VALKARIA, Fla., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ("Kaival Brands," the "Company," or "we"), today announced that it has appointed James W. Dobbins as General Counsel effective December 5, 2023.

Barry Hopkins, Executive Chairman of Kaival Brands, said, “James Dobbins has extensive experience advising companies on a breadth of legal matters, and importantly, he also has a deep, relevant understanding of industry business operations, including corporate governance, M&A, international sourcing, and compliance matters. Along with an anticipated reduction in legal expenses, we are thrilled to welcome James to guide and assist our executive leadership team as the Company seeks to execute upon a more aggressive growth strategy near term.”

Mr. Dobbins joins the Company with more than three decades of legal experience. Most notably, he served as Senior Vice President, General Counsel and Secretary for Turning Point Brands, Inc. (NYSE: TPB) He has expertise in corporate legal, public affairs and human resources matters including litigation, intellectual property, SEC reporting, M&A and structured finance, anti-counterfeiting, manufacturing, employment and regulatory affairs and compliance, marketing and sales, contracts, international sourcing (including China), governance, government relations, and FDA matters.

Prior to Turning Point Brands, he spent several years in private practice. Mr. Dobbins began his legal career with the law firm of Webster and Sheffield in New York. Prior to joining Kaival, he provided client counseling for litigation and other matters in various industries and served on the Board of Directors of both for-profit and non-profit organizations.

Mr. Dobbins earned a B.A. in Political Science and Mathematics from Drew University and a Juris Doctor (JD) from Fordham University.

$DYAI: Third Quarter Update Highlights year to date include:
https://scr.zacks.com/news/news-details/2023/DYAI-Third-Quarter-Update-article/default.aspx

"Unlocking Potential: Emerging Growth's Rising Stars Look Now! $ASPI, $VTAK, $INBS, $HNRC

https://www.marketscreener.com/quote/stock/ASP-ISOTOPES-INC-146590784/news/Unlocking-Potential-Emerging-Growth-s-Rising-Stars-Look-Now-ASPI-VTAK-INBS-HNRC-45559996/

ASP Isotopes Inc. (NASDAQ: ASPI) is a pre-commercial stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process ("ASP technology"). The Company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes). There is a growing demand for isotopes such as Silicon-28, which will enable quantum computing, and Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, and Uranium-235 for green energy applications. Watch ASPI's Parker Scott at Emerging Growth Here

Catheter Precision, Inc. (NYSE American: VTAK), a cutting-edge medical technology firm, revealed on December 5 that it had received an invitation to present at the Emerging Growth Conference scheduled for December 6, 2023. During the event, Catheter Precision will spotlight its groundbreaking non-invasive 3D mapping system, VIVO(TM), designed to assist physicians in pinpointing the source of ventricular arrhythmias before medical procedures while enhancing workflow efficiency and shortening procedure durations. This cost-effective and innovative remedy has obtained regulatory approval from the United States Food and Drug Administration (FDA) and is currently accessible for commercial use in Europe.

Watch VTAK's David Jenkins at Emerging Growth Here

Furthermore, VIVO(TM) 3D Mapping System's revolutionary potential was recently featured by "Cardiac Rhythm News" see complete news article: https://cardiacrhythmnews.com/catheter-precisions-vivo-3d-mapping-system-secures-reimbursement-in-nhs-englands-ssdp/

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a life sciences company. The Company is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint sweat using a one-time cartridge and portable handheld reader and also includes a development stage range of biosensor- based Point of Care diagnostic tests (POCT) that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology. Its product candidate is the Saliva Glucose Biosensor (SGB), a POCT expected to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. Its Biosensor Platform helps to detect multiple biological analytes. Watch INBS'Harry Simeonidis, President / CEO at Emerging Growth Here

Houston Natural Resources Corp (OTC: HNRC) stands as a versatile energy enterprise with stakes in both oil and gas. Notably, the company has successfully obtained full ownership, a 100% interest, in Cunningham Energy LLC, boasting appraised reserves totaling $352 million. Additionally, Houston Natural Resources Corp holds minority investments in Rhino Energy Ltd, CE Energy Sponsors, LLC, and HNR Acquisition Corp. The company encompasses mining ventures in copper, lithium, gold, as well as other valuable and rare earth metals. With a global perspective, the investment strategy is underpinned by a commitment to sustainability, making it an integral element of the company's core approach. Demonstrating a commitment to growth, the company remains proactive in its pursuit of new opportunities within the energy and energy transitions sectors, all with the overarching goal of delivering enhanced value to its shareholders. Watch HNRC's Frank Kristan, Chairman & CEO at Emerging Growth Here

$HALB "Halberd CorporationTackling the Global Healthcare Challenge of Traumatic Brain Injury"
https://www.marketscreener.com/quote/stock/HALBERD-5370657/news/Halberd-Corporation-OTC-HALB-Tackling-the-Global-Healthcare-Challenge-of-Traumatic-Brain-Injury-45532337/